Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection

C. V. McCarthy; F. G. Sandmann; CMMID COVID-19 Working Group

doi:10.1016/j.jhin.2021.02.012

Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection

C. V. McCarthy^*
, F. G. Sandmann
, CMMID COVID-19 Working Group

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	205-207
Number of pages	3
Journal	Journal of Hospital Infection
Volume	111
Early online date	20 Feb 2021
DOIs	https://doi.org/10.1016/j.jhin.2021.02.012
Publication status	Published - 1 May 2021

Access to Document

10.1016/j.jhin.2021.02.012

Cite this

@article{71c6fc473401481ea59947b171d657ac,

title = "Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection",

author = "McCarthy, \{C. V.\} and Sandmann, \{F. G.\} and \{CMMID COVID-19 Working Group\} and Eggo, \{R. M.\} and Knight, \{G. M.\} and S. Flasche and Foss, \{A. M.\} and P. Klepac and Y. Jafari and Waterlow, \{N. R.\} and Meakin, \{S. R.\} and J. Lei and Villabona-Arenas, \{C. J.\} and Procter, \{S. R.\} and S. Abbott and S. Funk and Bosse, \{N. I.\} and K. O'Reilly and W. Waites and K. Abbas and A. Gimma and A. Showering and Jarvis, \{C. I.\} and Kucharski, \{A. J.\} and A. Endo and T. Jombart and G. Medley and O. Brady and Barnard, \{R. C.\} and J. Williams and Davies, \{N. G.\} and Edmunds, \{W. J.\} and Munday, \{J. D.\} and Pearson, \{C. A.B.\} and Y. Liu and Atkins, \{K. E.\} and Gibbs, \{H. P.\} and Russell, \{T. W.\} and Tully, \{D. C.\} and R. Lowe and S. Clifford and Nightingale, \{E. S.\} and J. Hellewell and A. Rosello and M. Quaife and F. Krauer and \{Desmond Chan\}, \{Y. W.\} and Sun, \{F. Y.\} and \{van Zandvoort\}, K. and Quilty, \{B. J.\} and M. Koltai and K. Prem and M. Jit",

note = "Funding Information: Funding for the CMMID COVID-19 Working Group is as follows. RME: HDR UK (grant: MR/S003975/1 ), MRC (grant: MC\_PC 19065 ), NIHR (grant: NIHR200908 ). GMK: UK Medical Research Council (grant: MR/P014658/1 ). SFlasche: Wellcome Trust (grant: 208812/Z/17/Z ). PK: Royal Society (award RP/EA/180004), European Commission ( 101003688 ), Bill \& Melinda Gates Foundation ( INV-003174 ). YJ: LSHTM, DHSC/UKRI COVID-19 Rapid Response Initiative. NRW: Medical Research Council (grant: MR/N013638/1 ). SRM: Wellcome Trust (grant: 210758/Z/18/Z ). JYL: Bill \& Melinda Gates Foundation ( INV-003174 ). CJVA: European Research Council Starting Grant ( 757688 ). SRP: Bill and Melinda Gates Foundation ( INV-016832 ). SA: Wellcome Trust (grant: 210758/Z/18/Z ). SFunk: Wellcome Trust (grant: 210758/Z/18/Z ), NIHR ( NIHR200908 ). NIB: Health Protection Research Unit (grant: NIHR200908 ). KO'R: Bill and Melinda Gates Foundation ( OPP1191821 ). WW: MRC (grant: MR/V027956/1 ). KA: Bill \& Melinda Gates Foundation ( OPP1157270 , INV-016832 ). AG: European Commission ( EpiPose 101003688 ). MJ: Gates (INV-003174, INV-016832), NIHR (16/137/109, NIHR200929, NIHR200908), European Commission (EpiPose 101003688). CIJ: Global Challenges Research Fund (GCRF) project {\textquoteleft}RECAP{\textquoteright} managed through RCUK and ESRC (ES/P010873/1). AJK: Wellcome Trust (grant: 206250/Z/17/Z ), NIHR (NIHR200908). AE: The Nakajima Foundation. TJ: RCUK/ESRC (grant: ES/P010873/1), UK PH RST, NIHR HPRU Modelling \& Health Economics (NIHR200908). GFM: NTD Modelling Consortium by the Bill and Melinda Gates Foundation (OPP1184344). OJB: Wellcome Trust (grant: 206471/Z/17/Z). RCB: European Commission (EpiPose 101003688). JW: NIHR Health Protection Research Unit and NIHR HTA. NGD: UKRI Research England, NIHR Health Protection Research Unit in Immunisation (NIHR200929), UK MRC (MC\_PC\_19065). WJE: European Commission (EpiPose 101003688), NIHR (NIHR200908). JDM: Wellcome Trust (grant: 210758/Z/18/Z). CABP: Bill \& Melinda Gates Foundation (OPP1184344) and the UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z). YL: Gates (INV-003174), NIHR (16/137/109), European Commission (101003688). KEA: European Research Council Starting Grant (757688). FGS: NIHR Health Protection Research Unit in Modelling \& Health Economics, and in Immunisation. HPG: CSIGN which is part of the EDCTP2 programme supported by the European Union (grant: RIA2020EF-2983-CSIGN), Department of Health and Social Care (PR-OD-1017-20001). TWR: Wellcome Trust (grant: 206250/Z/17/Z). RL: Royal Society Dorothy Hodgkin Fellowship. SC: Wellcome Trust (grant: 208812/Z/17/Z). ESN: Gates (OPP1183986). JH: Wellcome Trust (grant: 210758/Z/18/Z). AR : NIHR (grant: PR-OD-1017-20002). MQ: European Research Council Starting Grant (\#757699), Bill and Melinda Gates Foundation (INV-001754). FK: Innovation Fund of the Joint Federal Committee (grant: 01VSF18015), Wellcome Trust (UNS110424). FYS: NIHR EPIC (grant:16/137/109). KvZ: UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z), Elrha{\textquoteright}s Research for Health in Humanitarian Crises (R2HC) Programme. BJQ: NIHR (16/137/109 \& 16/136/46). BJQ: Bill and Melinda Gates Foundation (OPP1139859). MK: Foreign, Commonwealth and Development Office/Wellcome Trust. KP: Gates (INV-003174), European Commission (101003688). Funding Information: This research was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunization at the London School of Hygiene and Tropical Medicine in partnership with Public Health England. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, UK Department of Health or Public Health England.Funding for the CMMID COVID-19 Working Group is as follows. RME: HDR UK (grant: MR/S003975/1), MRC (grant: MC\_PC 19065), NIHR (grant: NIHR200908). GMK: UK Medical Research Council (grant: MR/P014658/1). SFlasche: Wellcome Trust (grant: 208812/Z/17/Z). PK: Royal Society (award RP/EA/180004), European Commission (101003688), Bill \& Melinda Gates Foundation (INV-003174). YJ: LSHTM, DHSC/UKRI COVID-19 Rapid Response Initiative. NRW: Medical Research Council (grant: MR/N013638/1). SRM: Wellcome Trust (grant: 210758/Z/18/Z). JYL: Bill \& Melinda Gates Foundation (INV-003174). CJVA: European Research Council Starting Grant (757688). SRP: Bill and Melinda Gates Foundation (INV-016832). SA: Wellcome Trust (grant: 210758/Z/18/Z). SFunk: Wellcome Trust (grant: 210758/Z/18/Z), NIHR (NIHR200908). NIB: Health Protection Research Unit (grant:NIHR200908). KO'R: Bill and Melinda Gates Foundation (OPP1191821). WW: MRC (grant: MR/V027956/1). KA: Bill \& Melinda Gates Foundation (OPP1157270, INV-016832). AG: European Commission (EpiPose 101003688). MJ: Gates (INV-003174, INV-016832), NIHR (16/137/109, NIHR200929, NIHR200908), European Commission (EpiPose 101003688). CIJ: Global Challenges Research Fund (GCRF) project {\textquoteleft}RECAP{\textquoteright} managed through RCUK and ESRC (ES/P010873/1). AJK: Wellcome Trust (grant: 206250/Z/17/Z), NIHR (NIHR200908). AE: The Nakajima Foundation. TJ: RCUK/ESRC (grant: ES/P010873/1), UK PH RST, NIHR HPRU Modelling \& Health Economics (NIHR200908). GFM: NTD Modelling Consortium by the Bill and Melinda Gates Foundation (OPP1184344). OJB: Wellcome Trust (grant: 206471/Z/17/Z). RCB: European Commission (EpiPose 101003688). JW: NIHR Health Protection Research Unit and NIHR HTA. NGD: UKRI Research England, NIHR Health Protection Research Unit in Immunisation (NIHR200929), UK MRC (MC\_PC\_19065). WJE: European Commission (EpiPose 101003688), NIHR (NIHR200908). JDM: Wellcome Trust (grant: 210758/Z/18/Z). CABP: Bill \& Melinda Gates Foundation (OPP1184344) and the UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z). YL: Gates (INV-003174), NIHR (16/137/109), European Commission (101003688). KEA: European Research Council Starting Grant (757688). FGS: NIHR Health Protection Research Unit in Modelling \& Health Economics, and in Immunisation. HPG: CSIGN which is part of the EDCTP2 programme supported by the European Union (grant: RIA2020EF-2983-CSIGN), Department of Health and Social Care (PR-OD-1017-20001). TWR: Wellcome Trust (grant: 206250/Z/17/Z). RL: Royal Society Dorothy Hodgkin Fellowship. SC: Wellcome Trust (grant: 208812/Z/17/Z). ESN: Gates (OPP1183986). JH: Wellcome Trust (grant: 210758/Z/18/Z). AR: NIHR (grant: PR-OD-1017-20002). MQ: European Research Council Starting Grant (\#757699), Bill and Melinda Gates Foundation (INV-001754). FK: Innovation Fund of the Joint Federal Committee (grant: 01VSF18015), Wellcome Trust (UNS110424). FYS: NIHR EPIC (grant:16/137/109). KvZ: UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z), Elrha's Research for Health in Humanitarian Crises (R2HC) Programme. BJQ: NIHR (16/137/109 \& 16/136/46). BJQ: Bill and Melinda Gates Foundation (OPP1139859). MK: Foreign, Commonwealth and Development Office/Wellcome Trust. KP: Gates (INV-003174), European Commission (101003688). Funding Information: This research was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunization at the London School of Hygiene and Tropical Medicine in partnership with Public Health England . The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, UK Department of Health or Public Health England. ",

year = "2021",

month = may,

day = "1",

doi = "10.1016/j.jhin.2021.02.012",

language = "English",

volume = "111",

pages = "205--207",

journal = "Journal of Hospital Infection",

issn = "0195-6701",

publisher = "W.B. Saunders Company",

}

TY - JOUR

T1 - Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection

AU - McCarthy, C. V.

AU - Sandmann, F. G.

AU - CMMID COVID-19 Working Group

AU - Eggo, R. M.

AU - Knight, G. M.

AU - Flasche, S.

AU - Foss, A. M.

AU - Klepac, P.

AU - Jafari, Y.

AU - Waterlow, N. R.

AU - Meakin, S. R.

AU - Lei, J.

AU - Villabona-Arenas, C. J.

AU - Procter, S. R.

AU - Abbott, S.

AU - Funk, S.

AU - Bosse, N. I.

AU - O'Reilly, K.

AU - Waites, W.

AU - Abbas, K.

AU - Gimma, A.

AU - Showering, A.

AU - Jarvis, C. I.

AU - Kucharski, A. J.

AU - Endo, A.

AU - Jombart, T.

AU - Medley, G.

AU - Brady, O.

AU - Barnard, R. C.

AU - Williams, J.

AU - Davies, N. G.

AU - Edmunds, W. J.

AU - Munday, J. D.

AU - Pearson, C. A.B.

AU - Liu, Y.

AU - Atkins, K. E.

AU - Gibbs, H. P.

AU - Russell, T. W.

AU - Tully, D. C.

AU - Lowe, R.

AU - Clifford, S.

AU - Nightingale, E. S.

AU - Hellewell, J.

AU - Rosello, A.

AU - Quaife, M.

AU - Krauer, F.

AU - Desmond Chan, Y. W.

AU - Sun, F. Y.

AU - van Zandvoort, K.

AU - Quilty, B. J.

AU - Koltai, M.

AU - Prem, K.

AU - Jit, M.

N1 - Funding Information: Funding for the CMMID COVID-19 Working Group is as follows. RME: HDR UK (grant: MR/S003975/1 ), MRC (grant: MC_PC 19065 ), NIHR (grant: NIHR200908 ). GMK: UK Medical Research Council (grant: MR/P014658/1 ). SFlasche: Wellcome Trust (grant: 208812/Z/17/Z ). PK: Royal Society (award RP/EA/180004), European Commission ( 101003688 ), Bill & Melinda Gates Foundation ( INV-003174 ). YJ: LSHTM, DHSC/UKRI COVID-19 Rapid Response Initiative. NRW: Medical Research Council (grant: MR/N013638/1 ). SRM: Wellcome Trust (grant: 210758/Z/18/Z ). JYL: Bill & Melinda Gates Foundation ( INV-003174 ). CJVA: European Research Council Starting Grant ( 757688 ). SRP: Bill and Melinda Gates Foundation ( INV-016832 ). SA: Wellcome Trust (grant: 210758/Z/18/Z ). SFunk: Wellcome Trust (grant: 210758/Z/18/Z ), NIHR ( NIHR200908 ). NIB: Health Protection Research Unit (grant: NIHR200908 ). KO'R: Bill and Melinda Gates Foundation ( OPP1191821 ). WW: MRC (grant: MR/V027956/1 ). KA: Bill & Melinda Gates Foundation ( OPP1157270 , INV-016832 ). AG: European Commission ( EpiPose 101003688 ). MJ: Gates (INV-003174, INV-016832), NIHR (16/137/109, NIHR200929, NIHR200908), European Commission (EpiPose 101003688). CIJ: Global Challenges Research Fund (GCRF) project ‘RECAP’ managed through RCUK and ESRC (ES/P010873/1). AJK: Wellcome Trust (grant: 206250/Z/17/Z ), NIHR (NIHR200908). AE: The Nakajima Foundation. TJ: RCUK/ESRC (grant: ES/P010873/1), UK PH RST, NIHR HPRU Modelling & Health Economics (NIHR200908). GFM: NTD Modelling Consortium by the Bill and Melinda Gates Foundation (OPP1184344). OJB: Wellcome Trust (grant: 206471/Z/17/Z). RCB: European Commission (EpiPose 101003688). JW: NIHR Health Protection Research Unit and NIHR HTA. NGD: UKRI Research England, NIHR Health Protection Research Unit in Immunisation (NIHR200929), UK MRC (MC_PC_19065). WJE: European Commission (EpiPose 101003688), NIHR (NIHR200908). JDM: Wellcome Trust (grant: 210758/Z/18/Z). CABP: Bill & Melinda Gates Foundation (OPP1184344) and the UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z). YL: Gates (INV-003174), NIHR (16/137/109), European Commission (101003688). KEA: European Research Council Starting Grant (757688). FGS: NIHR Health Protection Research Unit in Modelling & Health Economics, and in Immunisation. HPG: CSIGN which is part of the EDCTP2 programme supported by the European Union (grant: RIA2020EF-2983-CSIGN), Department of Health and Social Care (PR-OD-1017-20001). TWR: Wellcome Trust (grant: 206250/Z/17/Z). RL: Royal Society Dorothy Hodgkin Fellowship. SC: Wellcome Trust (grant: 208812/Z/17/Z). ESN: Gates (OPP1183986). JH: Wellcome Trust (grant: 210758/Z/18/Z). AR : NIHR (grant: PR-OD-1017-20002). MQ: European Research Council Starting Grant (#757699), Bill and Melinda Gates Foundation (INV-001754). FK: Innovation Fund of the Joint Federal Committee (grant: 01VSF18015), Wellcome Trust (UNS110424). FYS: NIHR EPIC (grant:16/137/109). KvZ: UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z), Elrha’s Research for Health in Humanitarian Crises (R2HC) Programme. BJQ: NIHR (16/137/109 & 16/136/46). BJQ: Bill and Melinda Gates Foundation (OPP1139859). MK: Foreign, Commonwealth and Development Office/Wellcome Trust. KP: Gates (INV-003174), European Commission (101003688). Funding Information: This research was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunization at the London School of Hygiene and Tropical Medicine in partnership with Public Health England. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, UK Department of Health or Public Health England.Funding for the CMMID COVID-19 Working Group is as follows. RME: HDR UK (grant: MR/S003975/1), MRC (grant: MC_PC 19065), NIHR (grant: NIHR200908). GMK: UK Medical Research Council (grant: MR/P014658/1). SFlasche: Wellcome Trust (grant: 208812/Z/17/Z). PK: Royal Society (award RP/EA/180004), European Commission (101003688), Bill & Melinda Gates Foundation (INV-003174). YJ: LSHTM, DHSC/UKRI COVID-19 Rapid Response Initiative. NRW: Medical Research Council (grant: MR/N013638/1). SRM: Wellcome Trust (grant: 210758/Z/18/Z). JYL: Bill & Melinda Gates Foundation (INV-003174). CJVA: European Research Council Starting Grant (757688). SRP: Bill and Melinda Gates Foundation (INV-016832). SA: Wellcome Trust (grant: 210758/Z/18/Z). SFunk: Wellcome Trust (grant: 210758/Z/18/Z), NIHR (NIHR200908). NIB: Health Protection Research Unit (grant:NIHR200908). KO'R: Bill and Melinda Gates Foundation (OPP1191821). WW: MRC (grant: MR/V027956/1). KA: Bill & Melinda Gates Foundation (OPP1157270, INV-016832). AG: European Commission (EpiPose 101003688). MJ: Gates (INV-003174, INV-016832), NIHR (16/137/109, NIHR200929, NIHR200908), European Commission (EpiPose 101003688). CIJ: Global Challenges Research Fund (GCRF) project ‘RECAP’ managed through RCUK and ESRC (ES/P010873/1). AJK: Wellcome Trust (grant: 206250/Z/17/Z), NIHR (NIHR200908). AE: The Nakajima Foundation. TJ: RCUK/ESRC (grant: ES/P010873/1), UK PH RST, NIHR HPRU Modelling & Health Economics (NIHR200908). GFM: NTD Modelling Consortium by the Bill and Melinda Gates Foundation (OPP1184344). OJB: Wellcome Trust (grant: 206471/Z/17/Z). RCB: European Commission (EpiPose 101003688). JW: NIHR Health Protection Research Unit and NIHR HTA. NGD: UKRI Research England, NIHR Health Protection Research Unit in Immunisation (NIHR200929), UK MRC (MC_PC_19065). WJE: European Commission (EpiPose 101003688), NIHR (NIHR200908). JDM: Wellcome Trust (grant: 210758/Z/18/Z). CABP: Bill & Melinda Gates Foundation (OPP1184344) and the UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z). YL: Gates (INV-003174), NIHR (16/137/109), European Commission (101003688). KEA: European Research Council Starting Grant (757688). FGS: NIHR Health Protection Research Unit in Modelling & Health Economics, and in Immunisation. HPG: CSIGN which is part of the EDCTP2 programme supported by the European Union (grant: RIA2020EF-2983-CSIGN), Department of Health and Social Care (PR-OD-1017-20001). TWR: Wellcome Trust (grant: 206250/Z/17/Z). RL: Royal Society Dorothy Hodgkin Fellowship. SC: Wellcome Trust (grant: 208812/Z/17/Z). ESN: Gates (OPP1183986). JH: Wellcome Trust (grant: 210758/Z/18/Z). AR: NIHR (grant: PR-OD-1017-20002). MQ: European Research Council Starting Grant (#757699), Bill and Melinda Gates Foundation (INV-001754). FK: Innovation Fund of the Joint Federal Committee (grant: 01VSF18015), Wellcome Trust (UNS110424). FYS: NIHR EPIC (grant:16/137/109). KvZ: UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus Research Programme (ref. 221303/Z/20/Z), Elrha's Research for Health in Humanitarian Crises (R2HC) Programme. BJQ: NIHR (16/137/109 & 16/136/46). BJQ: Bill and Melinda Gates Foundation (OPP1139859). MK: Foreign, Commonwealth and Development Office/Wellcome Trust. KP: Gates (INV-003174), European Commission (101003688). Funding Information: This research was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunization at the London School of Hygiene and Tropical Medicine in partnership with Public Health England . The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, UK Department of Health or Public Health England.

PY - 2021/5/1

Y1 - 2021/5/1

UR - https://www.scopus.com/pages/publications/85103928445

U2 - 10.1016/j.jhin.2021.02.012

DO - 10.1016/j.jhin.2021.02.012

M3 - Letter

C2 - 33617936

AN - SCOPUS:85103928445

SN - 0195-6701

VL - 111

SP - 205

EP - 207

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

ER -

Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection

Access to Document

Other files and links

Cite this